Smart myoelectric hand prosthesis driven by embedded artificial intelligence

肌电控制臂允许上肢截肢者恢复能力和功能，从而与传统的身体动力假肢相比提高他们的自主性和生活质量。目前市场上的肌电控制器手臂并没有实现承诺。除了非常昂贵和不舒适之外，它们再现最终用户所期望的手势的保真度很低并且难以控制。BIO6 Inc.，一家加拿大初创企业，已经为自己设定了使命，通过改善舒适性，直观性和可及性来提高肌电假肢的接受率，这已被确定为三个主要的拒绝原因。BIO 6的方法包括在开发新产品时考虑最终用户的反馈，利用人工智能和生物医学仪器的惊人发展。利用多学科专业知识，长期成功的跟踪记录和国际合作，该项目的目标是在2年内设计，制造和测试一个强大且廉价的BIO 6肌电控制臂原型。这项国际合作依赖于一个多学科团队，包括四所大学，两个研究主席和两个代表加拿大生物医学技术和康复行业和公共部门的合作伙伴组织。他们将利用先进的医疗仪器和机器学习设计和测试新的肌电控制策略，这将提高肌电假肢的舒适性和直观性，从而提高最终用户的接受率和生活质量。与假肢设备初创公司BIO 6 Inc.的合作和临床合作伙伴CIUSSS Capitale-Nationale将通过密切合作带来可操作的结果和强大的现实世界影响。BIO 6将利用这一合作，迅速将成果转化为下一代假肢产品，更好地满足截肢者的需求，并将更便宜。公共合作伙伴CIUSSS将通过监督和指导所有设计阶段以及监督志愿者对原型的测试和验证，为最终用户的成功接受和转移铺平道路。

Myoelectric controlled-arms allow upper-limb amputees to recover abilities and functionality, and thus improve their autonomy and quality of life compared to traditional body-powered prostheses. The myoelectric controller arms currently on the market do not fulfill promises. In addition to being very expensive and not comfortable, they reproduce the hand gestures desired by the end-users with little fidelity and are difficult to control. BIO6 Inc., a Canadian start-up, has set itself the mission to increase the acceptance rate of myoelectric prostheses by improving the comfort, intuitiveness and accessibility, which have been identified as three major causes of rejection. BIO6's approach consists of taking the end-users' feedback into account in the development of their new product leveraging the spectacular developments in artificial intelligence and biomedical instrumentation. Leveraging a multidisciplinary expertise, a long successful track record, and an international collaboration, the goal of this project is to design, manufacture and test a robust and inexpensive prototype of the BIO6 myoelectric controlled arm within 2 years. This international collaboration counts on a multidisciplinary team, including four universities, two research Chairs, and two partner organizations representing the industry and the public sector in biomedical technology and rehabilitation in Canada. They will design and test new myoelectric control strategies drawing from advanced medical instrumentation and machine learning that will improve comfort and intuitiveness of myoelectric prostheses leading to a higher acceptance rate and quality of life for the end-users. This partnership with prosthetic device start-up BIO6 Inc. and clinical partner CIUSSS Capitale-Nationale will lead to actionable results and strong real-world impact through close cooperation. BIO6 will leverage this collaboration to quickly transform the results into the next-generation prostheses product that will better addresses amputee needs and will be less expensive. Public partner CIUSSS will pave the way for a successful acceptance and transfer to the end-users by overseeing and guide all design phases and by supervising the test and the validation of prototypes with volunteers.